by Truveta staff | May 6, 2025 | Culture
This week we gathered with leaders across healthcare, public health, and life sciences at the 3rd annual Truveta Symposium. Truveta Symposium uniquely brings together leaders from life science, public health, and healthcare organizations to collaborate on health...
by Truveta staff | Mar 20, 2025 | Data
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with chronic inflammatory infections. However, the traditional methods of studying these...
by Truveta staff | Aug 19, 2024 | News
Truveta was included in GeekWire’s latest list recognizing the top 200 startups in the Pacific Northwest. With this update of the GeekWire 200, Truveta moved up 14 spots to #38 as the highest-ranking healthcare startup on the list. The company was also included in the...
by Truveta staff | Aug 15, 2024 | Data
Psoriasis is more than just a skin condition – it’s a chronic, systemic disease that affects over 8 million people in the United States, profoundly impacting their quality of life. As a complex, immune-mediated disease, psoriasis presents a variety of challenges to...
by Truveta staff | Jun 14, 2024 | Data
One in every four US households has someone living with migraine. More than a severe headache, migraine is a complex neurological disorder impacting 39 million Americans with more than $36B lost each year in medical expenses and lost productivity. Despite its...
